154 related articles for article (PubMed ID: 10228796)
21. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
[TBL] [Abstract][Full Text] [Related]
22. [Cellular and humoral functions in acute pancreatitis].
Schulz HU; Schmidt D; Kunz D; Pross M; Gerber A; Weiss G; Sokolowski A; Struy H; Lippert H
Wien Med Wochenschr; 1997; 147(1):10-3. PubMed ID: 9133100
[TBL] [Abstract][Full Text] [Related]
23. A descriptive study of immune status in patients undergoing colorectal surgery: lymphocyte phenotypes.
Tax AW; Orsi AJ; Lafferty M; Barsevick A; Luborsky L; Prystowsky M; Nahass D; Lowery B; McCorkle R
Oncol Nurs Forum; 1994 Oct; 21(9):1539-44. PubMed ID: 7816679
[TBL] [Abstract][Full Text] [Related]
24. Soluble IL-2 receptor in patients with primary nephrotic syndrome.
Ohno I; Gomi H; Matsuda H; Nakano H; Matsumoto H; Kodama K; Shibasaki T; Ishimoto F; Sakai O
Nihon Jinzo Gakkai Shi; 1991 May; 33(5):483-9. PubMed ID: 1895547
[TBL] [Abstract][Full Text] [Related]
25. [The effect of adjuvant combined chemo/immunotherapy on immunological parameters and clinical course in patients with breast carcinoma].
Mallmann P; Krebs D
Zentralbl Gynakol; 1991; 113(12):697-706. PubMed ID: 1927119
[TBL] [Abstract][Full Text] [Related]
26. [Tumor-induced anemia and markers of inflammation].
Morant R; Bacchus L; Meyer J; Riesen WF
Schweiz Med Wochenschr; 1994 Dec; 124(50):2267-71. PubMed ID: 7809592
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory and hematopoietic effects of recombinant human interleukin-6 in patients with advanced renal cell cancer.
Schuler M; Peschel C; Schneller F; Fichtner J; Färber L; Huber C; Aulitzky WE
J Interferon Cytokine Res; 1996 Nov; 16(11):903-10. PubMed ID: 8938565
[TBL] [Abstract][Full Text] [Related]
28. In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a).
Ho HN; Wu MY; Chen HF; Chao KH; Yang YS; Huang SC; Lee TY; Gill TJ
Am J Reprod Immunol; 1995 Jan; 33(1):134-9. PubMed ID: 7619228
[TBL] [Abstract][Full Text] [Related]
29. [Activated T cells in the peripheral blood of patients with subacute myelo-optico-neuropathy (SMON)].
Matsuda M; Miyagi K; Yanagisawa N; Tsukada N
Arerugi; 1994 Mar; 43(3):515-20. PubMed ID: 8198461
[TBL] [Abstract][Full Text] [Related]
30. A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studies.
Ghosh AK; Smith NK; Prendiville J; Thatcher N; Crowther D; Stern PL
Eur Cytokine Netw; 1993; 4(3):205-11. PubMed ID: 8218945
[TBL] [Abstract][Full Text] [Related]
31. [Abnormalities of cellular immunity in uremic patients].
Matsumoto Y
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):733-42. PubMed ID: 8377286
[TBL] [Abstract][Full Text] [Related]
32. Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.
Mallmann P; Krebs D
Methods Find Exp Clin Pharmacol; 1990 Jun; 12(5):333-40. PubMed ID: 2232966
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
[TBL] [Abstract][Full Text] [Related]
34. [Palliative therapy in cancer. 6. Quality of life and BRM therapy in cancer-patients].
Urushizaki I
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2119-29. PubMed ID: 1699499
[TBL] [Abstract][Full Text] [Related]
35. Preoperative natural killer cell activity: correlation with distant metastases in curatively research colorectal carcinomas.
Koda K; Saito N; Takiguchi N; Oda K; Nunomura M; Nakajima N
Int Surg; 1997; 82(2):190-3. PubMed ID: 9331851
[TBL] [Abstract][Full Text] [Related]
36. The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy.
Parera M; Rivera F; Egido J; Campos A
Clin Immunol Immunopathol; 1992 May; 63(2):196-9. PubMed ID: 1351798
[TBL] [Abstract][Full Text] [Related]
37. Intra-operative electron beam radiotherapy and abdomino-pelvic surgery for cancer: influence on immunological parameters.
Bussières E; Richaud P; Gualde N
Eur J Surg Oncol; 1992 Oct; 18(5):425-32. PubMed ID: 1426291
[TBL] [Abstract][Full Text] [Related]
38. Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance.
Xie Y; Zhang T; Su R; Liu L; Jiang L; Xue H; Gao C; Li X; Wang C
Clin Exp Med; 2023 Nov; 23(7):3605-3617. PubMed ID: 37528249
[TBL] [Abstract][Full Text] [Related]
39. Immune changes in peripheral blood resulting from locally directed interleukin-2 therapy in squamous cell carcinoma of the head and neck.
Dadian G; Riches PG; Henderson DC; MacLennan K; Lorentzos A; Moore J; Hobbs JR; Gore ME
Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):29-34. PubMed ID: 8180573
[TBL] [Abstract][Full Text] [Related]
40. Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
Song G; Wang X; Jia J; Yuan Y; Wan F; Zhou X; Yang H; Ren J; Gu J; Lyerly HK
Cancer Immunol Immunother; 2013 Jun; 62(6):1123-30. PubMed ID: 23604172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
